4.8 Article

MED1 mediator subunit is a key regulator of hepatic autophagy and lipid metabolism

Journal

AUTOPHAGY
Volume 17, Issue 12, Pages 4043-4061

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2021.1899691

Keywords

Autophagy; lipid oxidation; liver; med1; starvation

Categories

Funding

  1. National Medical Research Council [NMRC/OFYIRG/0002/2016, MOH-000319, MOH-000306]
  2. Duke-NUS Medical School
  3. Estate of Tan Sri Khoo Teck Puat Khoo Pilot Award [Duke-NUS-KP (Coll)/2018/0007A]

Ask authors/readers for more resources

The study demonstrated that MED1 plays a crucial role in regulating hepatic autophagy, mitochondria function, and lipid metabolism. It may affect the transcriptional activity of various NRs and transcription factors, and contribute to the development of nonalcoholic fatty liver disease.
Hepatic macroautophagy/autophagy and fatty acid metabolism are transcriptionally regulated by nuclear receptors (NRs); however, it is not known whether their transcriptional co-activators are involved in autophagy. We thus examined MED1 (mediator complex subunit 1), a key component of the Mediator Complex that directly interacts with NRs, on these processes. We found that MED1 knockdown (KD) in cultured hepatic cells decreased autophagy and mitochondrial activity that was accompanied by decreased transcription of genes involved in these processes. Lipophagy and fatty acid beta-oxidation also were impaired. These effects also occurred after thyroid hormone stimulation, nutrient-replete or -deplete conditions, and in liver-specific Med1 KD (Med1 LKD) mice under fed and fasting conditions. Together, these findings showed that Med1 played a key role in hepatic autophagy, mitochondria function, and lipid metabolism under these conditions. Additionally, we identified downregulated hepatic genes in Med1 LKD mice, and subjected them to ChIP Enrichment Analysis. Our findings showed that the transcriptional activity of several NRs and transcription factors (TFs), including PPARA and FOXO1, likely were affected by Med1 LKD. Finally, Med1 expression and autophagy also were decreased in two mouse models of nonalcoholic fatty liver disease (NAFLD) suggesting that decreased Med1 may contribute to hepatosteatosis. In summary, MED1 plays an essential role in regulating hepatic autophagy and lipid oxidation during different hormonal and nutrient conditions. Thus, MED1 may serve as an integrator of multiple transcriptional pathways involved in these metabolic processes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Caffeine prevents restenosis and inhibits vascular smooth muscle cell proliferation through the induction of autophagy

Madhulika Tripathi, Brijesh Kumar Singh, Elisa A. Liehn, Sheau Yng Lim, Keziah Tikno, David Castano-Mayan, Chutima Rattanasopa, Pakhwan Nilcham, Siti Aishah Binte Abdul Ghani, Zihao Wu, Syaza Hazwany Azhar, Jin Zhou, Sauri Hernandez-Resendiz, Gustavo E. Crespo-Avilan, Rohit Anthony Sinha, Benjamin Livingston Farah, Kyaw Thu Moe, Deidre Anne De Silva, Veronique Angeli, Manvendra K. Singh, Roshni R. Singaraja, Derek J. Hausenloy, Paul Michael Yen

Summary: Caffeine reduces vascular smooth muscle cell proliferation and restenosis by stimulating autophagy and inhibiting WNT signaling.

AUTOPHAGY (2022)

Article Biochemistry & Molecular Biology

Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse

Sangam Rajak, Pratima Gupta, Baby Anjum, Sana Raza, Archana Tewari, Sujoy Ghosh, Madhulika Tripathi, Brijesh K. Singh, Rohit A. Sinha

Summary: NASH is an important stage of NAFLD in humans, and there are currently no approved drugs for its treatment. The upregulation of AKR1B10 gene in NASH patients has been identified, and the inhibition of AKR1B10 has shown promising effects in reducing the pathological features of NASH.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)

Article Endocrinology & Metabolism

Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis

Jin Zhou, Madhulika Tripathi, Jia Pei Ho, Anissa Anindya Widjaja, Shamini Guna Shekeran, Macalinao Dominique Camat, Anne James, Yajun Wu, Jianhong Ching, Jean-Paul Kovalik, Kiat-Hon Lim, Stuart Alexander Cook, Boon-Huat Bay, Brijesh Kumar Singh, Paul Michael Yen

Summary: This study found that thyroid hormone can treat NASH-associated hepatic inflammation and fibrosis by promoting autophagy and mitochondrial biogenesis, increasing the oxidation of fatty acids, and reducing lipotoxicity, oxidative stress, and inflammation.

THYROID (2022)

Editorial Material Pharmacology & Pharmacy

Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19

Sugunadevi Sakkiah, Brijesh Kumar Singh, Keun Woo Lee, Chandrabose Selvaraj

FRONTIERS IN PHARMACOLOGY (2022)

Article Gastroenterology & Hepatology

Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation

Madhulika Tripathi, Brijesh Kumar Singh, Jin Zhou, Keziah Tikno, Anissa Widjaja, Reddemma Sandireddy, Kabilesh Arul, Siti Aishah Binte Abdul Ghani, George Goh Boon Bee, Kiraely Adam Wong, Ho Jia Pei, Shamini Guna Shekeran, Rohit Anthony Sinha, Manvendra K. Singh, Stuart Alexander Cook, Ayako Suzuki, Teegan Reina Lim, Chang-Chuen Cheah, Jue Wang, Rui-Ping Xiao, Xiuqing Zhang, Pierce Kah Hoe Chow, Paul Michael Yen

Summary: The study reveals that hyperhomocysteinemia (HHcy) plays a key role in the pathogenesis of non-alcoholic steatohepatitis (NASH) through homocysteinylation of proteins, leading to autophagy blockage. Vitamin B-12 and folate may serve as a novel first-line therapy for NASH by reducing homocysteine levels and promoting autophagy, thus improving liver histology.

JOURNAL OF HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Reply to: B vitamins for NASH: Use methylcobalamin, not cyanocobalamin

Madhulika Tripathi, Brijesh Kumar Singh, Paul Michael Yen

JOURNAL OF HEPATOLOGY (2023)

Review Endocrinology & Metabolism

A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications

Aline C. C. Fenneman, Eveline Bruinstroop, Max Nieuwdorp, Anne H. H. van der Spek, Anita Boelen

Summary: The gut is a target organ of thyroid hormone and gut microbiota play a role in TH metabolism. Disruption of gut microbial homeostasis is associated with autoimmune thyroid disease. Further research and clinical trials are needed to understand the cause-effect mechanisms and develop microbiota-based therapies.

THYROID (2023)

Article Multidisciplinary Sciences

Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression

Jin Zhou, Jeremy Pang, Madhulika Tripathi, Jia Pei Ho, Anissa Anindya Widjaja, Shamini Guna Shekeran, Stuart Alexander Cook, Ayako Suzuki, Anna Mae Diehl, Enrico Petretto, Brijesh Kumar Singh, Paul Michael Yen

Summary: The study found that spermidine can restore liver cell function impaired by non-alcoholic steatohepatitis (NASH) and prevent the progression of NASH in mice.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice

Sangam Rajak, Archana Tewari, Sana Raza, Pratima Gupta, Bandana Chakravarti, Baby Anjum, Madhulika Tripathi, Brijesh K. Singh, Paul M. Yen, Amit Goel, Sujoy Ghosh, Rohit A. Sinha

Summary: Nonalcoholic steatohepatitis (NASH) is a pivotal stage in the progression of nonalcoholic fatty liver disease (NAFLD) and increases the risk of serious liver diseases. Identifying reliable molecular players in the etiology of NASH has been difficult. Furthermore, there are currently no approved drugs for NASH treatment. This study highlights the involvement of CFTR in the pathogenesis of NASH and suggests the possibility of its pharmacological inhibition in human NASH.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

Editorial Material Biochemistry & Molecular Biology

Metabolic switching of estrogen-related receptor alpha in breast cancer aggression

Madhulika Tripathi, Brijesh Kumar Singh

Summary: Orphan nuclear receptor estrogen-related receptor alpha (ERR alpha) plays a crucial role in regulating energy metabolism, but its hyperactivation in breast cancer leads to cell migration, proliferation, and tumour development. The study by Brindisi et al. reveals that cholesterol can activate ERR alpha endogenously, promoting breast cancer aggressiveness, highlighting the potential anti-tumour effects of cholesterol-lowering drugs like statins.

FEBS JOURNAL (2023)

Article Endocrinology & Metabolism

Sex Steroids Regulate Liver Fat Content and Body Fat Distribution in Both Men and Women: A Study in Transgender Persons

Marieke Tebbens, Moya Schutte, Marian A. Troelstra, Eveline Bruinstroop, Renee de Mutsert, Aart J. Nederveen, Martin den Heijer, Peter H. Bisschop

Summary: This study investigated the effects of hormone treatment on liver fat and visceral fat in transgender individuals. The results showed that estrogen treatment reduced liver fat content in trans women, but had no effect on visceral fat. Testosterone treatment, on the other hand, increased both liver fat content and visceral fat volume in trans men.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Review Endocrinology & Metabolism

Role of hepatic deiodinases in thyroid hormone homeostasis and liver metabolism, inflammation, and fibrosis

Eveline Bruinstroop, Anne H. van der Spek, Anita Boelen

Summary: Thyroid hormones are crucial for maintaining bodily balance, and deiodinases play a vital role in regulating their concentration. Deiodinases convert thyroid hormone from its inactive form T4 to the active hormone T3, as well as convert them to their inactive metabolites rT3 and 3,3'-T2. This review focuses on the significance of liver deiodinases in determining thyroid hormone concentrations, liver metabolism, and liver disease.

EUROPEAN THYROID JOURNAL (2023)

Review Endocrinology & Metabolism

Role of thyroid hormone in an experimental model of atherosclerosis: the potential mediating role of immune response and autophagy

Kenji Ohba, Takayuki Iwaki

Summary: This article summarizes recent advances in research on the dynamic interaction between thyroid hormone status and immune response in the pathogenesis of atherosclerosis. The study suggests that thyroid hormone-mediated autophagy could serve as a novel therapeutic approach for atherosclerosis.

ENDOCRINE JOURNAL (2022)

Review Endocrinology & Metabolism

Role of thyroid hormone in an experimental model of atherosclerosis: the potential mediating role of immune response and autophagy

Kenji Ohba, Takayuki Iwaki

Summary: This article provides an overview of the dynamic interactions between thyroid hormone status and immune response in the pathogenesis of atherosclerosis. The role of macrophages and T-lymphocytes as important determinants in the initiation and development of atherosclerosis is highlighted. The study also suggests that thyroid hormone-mediated autophagy could serve as a novel therapeutic approach for atherosclerosis.

ENDOCRINE JOURNAL (2022)

Article Endocrinology & Metabolism

Clinical outcomes of 34 patients with resistance to thyroid hormone beta: a twenty-year experience in Japan

Kenji Ohba, Shigekazu Sasaki, Hiroko Misawa Nakamura, Akio Matsushita, Go Kuroda, Yuki Sakai, Hirotoshi Nakamura

Summary: Resistance to thyroid hormone beta caused by germline mutations in genes encoding thyroid hormone receptor beta is a rare disorder in Japan. Diagnostic delay and inappropriate management are still present, and the syndrome is often comorbid with additional autoimmune thyroid disorders.

ENDOCRINE JOURNAL (2022)

No Data Available